| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.095 | 0.005 |